Lv4
674 积分 2020-08-12 加入
A Retrospective Study of Ensartinib-Treated ALK -Positive Locally Advanced or Metastatic NSCLC Patients in China
2天前
已完结
A Retrospective Study of Ensartinib-Treated ALK -Positive Locally Advanced or Metastatic NSCLC Patients in China
2天前
已关闭
Efficacy of befotertinib in non-small cell lung cancer harboring uncommon compound EGFR mutations G719X and S768I: a case report
7天前
已关闭
Befotertinib (D-0316) versus icotinib as first-line therapy for patients with EGFR-mutated locally advanced or metastatic non-small-cell lung cancer: a multicentre, open-label, randomised phase 3 study
7天前
已完结
[Chinese Medical Association guideline for clinical diagnosis and treatment of lung cancer (2024 edition)]
7天前
已完结
蒙特利尔认知评价替代版mocav73-montrealcognitive
15天前
已关闭
Intrapericardial bevacizumab safely and effectively treats malignant pericardial effusion in advanced cancer patients
19天前
已完结
The Society of Thoracic Surgeons (STS) Clinical Practice Guideline on Surgical Management of Oligometastatic Non-small Cell Lung Cancer
22天前
已完结
Updated overall survival and final progression-free survival data for patients with treatment-naive advanced ALK-positive non-small-cell lung cancer in the ALEX study
1个月前
已完结
Osimertinib after Chemoradiotherapy in Stage III EGFR-Mutated NSCLC
1个月前
已完结
皖公网安备34019202002308
